Prostate-Specific Membrane Antigen (PSMA), another target for imaging tracers, is a transmembrane protein that is highly overexpressed in prostate cancer compared to normal prostate and non-prostatic tissues (Ristau et al., 2014). Here, FOLH1 is linked to prostate cancer.